e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Biomarker-based asthma control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population
G. Tavernier (Manchester, United Kingdom)
Source:
International Congress 2017 – Biomarker-based asthma control
Session:
Biomarker-based asthma control
Session type:
Thematic Poster
Number:
3992
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Tavernier (Manchester, United Kingdom). Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population. 3992
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO.
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Monitoring of sputum eosinophils in long-term treatment of bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 111s
Year: 2002
Impact on steroid dosing after introducing sputum eosinophils count into a severe asthma clinic
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations
Source: Eur Respir J 2006; 27: 483-494
Year: 2006
The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Role of sputum eosinophil levels in the assessment of asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 579s
Year: 2004
Eosinophilic inflammation in sputum of poorly controlled asthmatics
Source: Eur Respir J 2002; 20: 1370-1377
Year: 2002
Impact of the eosinophil variability on severe exacerbations in an asthmatic population
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020
Mechanisms of noneosinophilic asthma
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Can blood eosinophils predict sputum eosinophils in stable COPD?
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Year: 2006
High sputum ECP levels detect functional impairment in asthma better than sputum eosinophils
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Induced sputum and blood T lymphocyte activation during exacerbations of severe asthmatics: the ISEA study
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006
Comparison of N
ε
-(carboxymethyl)lysine levels and percentage of eosinophils in induced sputum for assessment of small airway involvements in asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Sputum neutrophilic markers in asthma of varying severity and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 550s
Year: 2003
Absence of sputum eosinophils in subjects with symptomatic asthma on inhaled budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 274s
Year: 2002
Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 594s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept